Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: Does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?

Prenatal Diagnosis

Volumn 35, Issue 3, 2015, Pages 308-309

  Grati, Francesca Romana ^a   Malvestiti, Francesca ^a   Grimi, Beatrice ^a   Liuti, Rosaria ^a   Agrati, Cristina ^a   Gaetani, Elisa ^a   Milani, Silvia ^a   Martinoni, Lorenza ^a   Zanatta, Valentina ^a   Gallazzi, Gloria ^a   Maggi, Federico ^a   Simoni, Giuseppe ^a  

^a TOMA Advanced Biomedical Assays SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AMNIOCENTESIS; AMNION CELL; ANEUPLOIDY; APOPTOSIS; CELL FREE SYSTEM; CELL LINEAGE; CHROMOSOME; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; CYTOTROPHOBLAST; HUMAN; INTERPHASE; KARYOTYPE; KARYOTYPING; LETTER; MATERNAL BLOOD; METAPHASE; MONOSOMY X; MOSAICISM; NONINVASIVE PRENATAL SCREENING; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RISK; SEX CHROMOSOME ABERRATION; SYNCYTIOTROPHOBLAST; TRIPLOIDY; TRISOMY 18; TRISOMY 21; AMNION; BLOOD; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDERS; CYTOLOGY; DOWN SYNDROME; FEMALE; FETUS; GENETICS; METABOLISM; PREGNANCY; PROCEDURES; TRISOMY; TURNER SYNDROME;

AMNIOCENTESIS; AMNION; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CYTOGENETIC ANALYSIS; DNA; DOWN SYNDROME; FEMALE; FETUS; HUMANS; MOSAICISM; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY; TURNER SYNDROME;

EID: 84924133410     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4483     Document Type: Letter

References (16)

1. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, et al. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169:400-4.
2. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod 2004;19:723-4.
3. Faas BH, de Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 2012;12(Suppl 1):S19-26.6-8.
4. Simoni G, Brambati B, Danesino C, et al. Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet 1983;63:349-57.
5. Bianchi DW, Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem 2014;60:78-87.
6. Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014;16:620-4.
7. Italian Society of Human Genetics (SIGU) statement on NIPT, 2014. URL. http://sigu.net/index.php?limitstart=10 [accessed on 7 July 2014].
8. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395-8.
9. Peter Benn, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013;33:622-9
10. Wilson KL, Czerwinski JL, Hoskovec JM, et al. NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns 2013;22:4-15.
11. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. American College of Obstetricians and Gynecologists Committee on Genetics. Obstet Gynecol 2012;120:1532-4
12. Salomon LJ, Alfirevic Z, Audibert F, et al. ISUOG Clinical Standards Committee. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet Gynecol 2014;44:122-3
13. Standard SIGU, Gestione Per La Qualità Nei Laboratori Di Genetica Medica e dei relativi INDICATORI. URL. http://www.sigu.net/index.php?option=com_content&view=article&id=474:standard-sigu-gestione-per-la-qualita-nei-laboratori-di-geneticamedica&catid=56:in-evidenza&Itemid=1 [accessed on 7 July 2014].
14. Hastings R, Howell R, Bricarelli FD, et al. URL. http://e-c-a.eu/files/downloads/E.C.A._General_Guidelines_Version%202.0.pdf [accessed on 7 July 2014].
15. Grati FR. Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. J Clin Med 2014;3:809-37.
16. Association for Clinical Cytogenetics (ACC). Professional guidelines for clinical cytogenetics, prenatal diagnosis best practice guidelines: amniotic fluid, version 1.01, 2009. URL. http://www.cytogenetics.org.uk [accessed on 2 September 2014].